The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function
Our better understanding of the weight regulation mechanisms and the role of gut-brain axis on appetite has led to the development of safe and effective entero-pancreatic hormone-based treatments for obesity such as glucagon-like peptide-1 (GLP-1) receptor agonists (RA)
If you have a history of weight cycling, consider this when planning your GLP-1 treatment duration
International Journal of Behavioral Nutrition and Physical Activity , 6 (1), 41
Pricing varies by clinic, so it pays to compare a few providers in the IA area
Insurance coverage for anti-obesity medications varies [58], leading to inconsistent access across different populations